Lee E. Moore

7.7k citations

97 papers · 6.3k · 1 hit paper · h-index 46

Impact in

Cancer Research top 1%
- Cancer Genomics and Diagnostics
Health, Toxicology and Mutagenesis top 1%
- Heavy Metal Exposure and Toxicity

Papers in

Cancer Research 18
- Carcinogens and Genotoxicity Assessment 9
Molecular Biology 47
- Epigenetics and DNA Methylation 23
- Glutathione Transferases and Polymorphisms 9

Co-authors: Nathaniel Rothman (24 shared papers)Sara Karami (19 shared papers)Ruth Pfieffer (7 shared papers)Allan Herries Smith (4 shared papers)Debra T. Silverman (14 shared papers)Stephen Jacob Chanock (10 shared papers)Vladimír Janout (15 shared papers)Paul Brennan (15 shared papers)
Journals: Cancer Epidemiology Biomarkers & Prevention (9 papers)International Journal of Cancer (9 papers)Occupational and Environmental Medicine (6 papers)PLoS ONE (5 papers)JNCI Journal of the National Cancer Institute (4 papers)
Partner nations: United States France Czechia

In The Last Decade

Lee E. Moore

97 papers receiving 6.2k citations

Lee E. Moore's Hit Papers

align trajectories log scale

Improved Identification of von Hippel-Lindau Gene Alterations in Clear Cell Renal Tumors 2008 · 505 citations

What are hit papers?

Paper score: A paper's citations measured against the top-1% bar of its own field and year: the square root of citations ÷ bar, so 1 means right at the bar and 2 means four times its citations. The bar blends the citation counts that enter the top 1% of the paper's subfields in its year (weighted 89.5%), of those subfields over all years (0.5%) and of its year across all fields (10%); a subfield and year with fewer than 400 papers takes its year's bar. Papers from 2026 are not scored yet: in an unfinished year, when a paper appeared matters more than how it is cited.

Hit paper: A paper cited at least 1.5× the top-1% bar of its field and year: a paper score of at least √1.5.

2008 Clinical Cancer Research

Peers

Countries citing papers authored by Lee E. Moore

Since Specialization

Citations

This map shows the geographic impact of Lee E. Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lee E. Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lee E. Moore more than expected).

Fields of papers citing papers by Lee E. Moore

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lee E. Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lee E. Moore. The network helps show where Lee E. Moore may publish in the future.

Co-authors

The 25 scholars most cited alongside Lee E. Moore, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lee E. Moore Line = papers co-authored together Lee E. Moore links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 97 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Improved Identification of von Hippel-Lindau Gene Alterations in Clear Cell Renal Tumors Clinical Cancer Research ·Michael L. Nickerson, Erich Jaeger, Yangu Shi, Jeffrey A. Durocher, Sunil Mahurkar, David Georgievich Zaridze, Vsevolod Borisovich Matveev, Vladimír Janout Hit paper breakdown →	2008	505
2	Detectable clonal mosaicism and its relationship to aging and cancer Nature Genetics ·Kevin B. Jacobs, Meredith Yeager, Weiyin Zhou, Sholom Wacholder, Zhaoming Wang, Benjamín Rodríguez‐Santiago, Amy A Hutchinson, Xiang Deng	2012	479
3	Circulating 25-Hydroxyvitamin D and Risk of Kidney Cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers American Journal of Epidemiology ·Lisa M. Gallicchio, Lee E. Moore, Victoria L. Stevens, Jiyoung Ahn, Demetrius Albanes, Virginia W. Hartmuller, Veronica Wendy Setiawan, Kathy J. Helzlsouer	2010	212
4	Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3 Nature Genetics ·Mark P. Purdue, Mattias Johansson, Diana Zélénika, Jorge R. Toro, Ghislaine Scélo, Lee E. Moore, Egor Prokhortchouk, Xifeng Wu	2010	211
5	Genomic DNA hypomethylation as a biomarker for bladder cancer susceptibility in the Spanish Bladder Cancer Study: a case–control study The Lancet Oncology ·Lee E. Moore, Ruth Pfieffer, Cristina Poscablo, Francisco X. Real, Manolis Kogevinas, Debra T. Silverman, Reina García-Closas, Stephen Jacob Chanock	2008	202
6	Von Hippel-Lindau (VHL) Inactivation in Sporadic Clear Cell Renal Cancer: Associations with Germline VHL Polymorphisms and Etiologic Risk Factors PLoS Genetics ·Lee E. Moore, Michael L. Nickerson, Paul Brennan, Jorge R. Toro, Erich Jaeger, Jessica L. Rinsky, Summer S. Han, David Georgievich Zaridze	2011	170
7	Occupational Exposure to Formaldehyde, Hematotoxicity, and Leukemia-Specific Chromosome Changes in Cultured Myeloid Progenitor Cells Cancer Epidemiology Biomarkers & Prevention ·Luoping Zhang, Xiaojiang Tang, Nathaniel Rothman, Roel C.H. Vermeulen, Zhiying Ji, Chuangyi Qiu, Weihong Guo, Songwang Liu	2010	169
8	Arsenic Methylation and Bladder Cancer Risk in Case???Control Studies in Argentina and the United States Journal of Occupational and Environmental Medicine ·Craig Steinmaus, Michael Bates, Yan Yuan, Dave Kalman, Raja H. Atallah, Mary Lou Biggs, Claudia Hopenhayn, Lee E. Moore	2006	157
9	A Framework for Evaluating Biomarkers for Early Detection: Validation of Biomarker Panels for Ovarian Cancer Cancer Prevention Research ·Claire S. Zhu, Paul F. Pinsky, Daniel William Cramer, David F. Ransohoff, Patricia A. Hartge, Ruth Pfieffer, Nicole D. Urban, Mor Gil	2011	150
10	Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for Thirteen Cancer Types JNCI Journal of the National Cancer Institute ·Joshua Neil Sampson, William A. Wheeler, Meredith Yeager, Orestis A. Panagiotou, Zhaoming Wang, Sonja I. Berndt, Qing Lan, Christian C. Abnet	2015	142
11	Methods for etiologic and early marker investigations in the PLCO trial Mutation research. Fundamental and molecular mechanisms of mutagenesis ·Richard B. Hayes, Alice J. Sigurdson, Lee E. Moore, Ulrike Peters, Wen‐Yi Huang, Paul F. Pinsky, Douglas J. Reding, Edward Paul Gelmann	2005	131
12	Elevated Bladder Cancer in Northern New England: The Role of Drinking Water and Arsenic JNCI Journal of the National Cancer Institute ·Dalsu Baris, Richard D. Waddell, Laura Beane Freeman, Molly R. Schwenn, Joanne S. Colt, Joseph D. Ayotte, Mary H. Ward, John R. Nuckols	2016	131
13	Selective amplification of additional members of the ADP-ribosylation factor (ARF) family: cloning of additional human and Drosophila ARF-like genes. Proceedings of the National Academy of Sciences ·J Clark, Lee E. Moore, Alyssa M. Krasinskas, James Way, James F. Battey, John W. Tamkun, Richard Kahn	1993	119
14	Female chromosome X mosaicism is age-related and preferentially affects the inactivated X chromosome Nature Communications ·Mitchell J. Machiela, Weiyin Zhou, Eric Karlins, Joshua Neil Sampson, Neal D. Freedman, Qi Yang, Belynda D. Hicks, Casey L. Dagnall	2016	109
15	Occupational Trichloroethylene Exposure and Renal Carcinoma Risk: Evidence of Genetic Susceptibility by Reductive Metabolism Gene Variants Cancer Research ·Lee E. Moore, Paolo Boffetta, Sara Karami, Paul Brennan, PATRICIA S. STEWART, David Georgievich Zaridze, Vsevolod Borisovich Matveev, Vladimír Janout	2010	98
16	Concurrent Alterations in TERT , KDM6A , and the BRCA Pathway in Bladder Cancer Clinical Cancer Research ·Michael L. Nickerson, Garrett M. Dancik, Kate McGee Im, Michael G. Edwards, Sevilay Turan, Joseph Brown, Christina Ruiz-Rodriguez, Charles R. Owens	2014	98
17	Case-Control Study of Arsenic in Drinking Water and Kidney Cancer in Uniquely Exposed Northern Chile American Journal of Epidemiology ·Catterina Ferreccio, Allan Herries Smith, Viviana Durán, Teresa Barlaro, Hugo Benítez, Rodrigo Valdés, Juan José Calvo Aguirre, Lee E. Moore	2013	97
18	Genome-wide association study identifies multiple risk loci for renal cell carcinoma Nature Communications ·Ghislaine Scélo, Mark P. Purdue, Kevin M. Brown, Mattias Johansson, Zhaoming Wang, Eckel-Passow Jeanette E., Yuanqing Ye, Jonathan N. Hofmann	2017	96
19	Obesity and cancer: Mendelian randomization approach utilizing the FTO genotype International Journal of Epidemiology ·Paul Brennan, James McKay, Lee E. Moore, David Zaridze, Anush Mukeria, Neonila Szeszenia‐Dąbrowska, Jolanta Lissowska, Peter Rudnai	2009	95
20	Application of OMICS technologies in occupational and environmental health research; current status and projections Occupational and Environmental Medicine ·Jelle J. Vlaanderen, Lee E. Moore, Martyn T. Smith, Qing Lan, lihai Zhang, Christine F. Skibola, Nathaniel Rothman, Roel C.H. Vermeulen	2009	92

About Lee E. Moore

Lee E. Moore is a scholar working on Cancer Research, Molecular Biology, Pulmonary and Respiratory Medicine, Genetics and Health, Toxicology and Mutagenesis, having authored 97 papers that have together received 6.3k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (23 papers), Bladder and Urothelial Cancer Treatments (12 papers), Genetic Associations and Epidemiology (11 papers), Renal cell carcinoma treatment (11 papers), Carcinogens and Genotoxicity Assessment (9 papers), Glutathione Transferases and Polymorphisms (9 papers), Vitamin D Research Studies (7 papers) and Folate and B Vitamins Research (7 papers). The work is most often cited by research in Cancer Research (1.3k citations), Health, Toxicology and Mutagenesis (763 citations), Environmental Chemistry (457 citations), Pulmonary and Respiratory Medicine (1.2k citations) and Molecular Biology (2.7k citations). Lee E. Moore has collaborated with scholars based in United States, France and Czechia. Frequent co-authors include Nathaniel Rothman, Sara Karami, Ruth Pfieffer, Allan Herries Smith, Debra T. Silverman, Stephen Jacob Chanock, Vladimír Janout, Paul Brennan, Dana Mateș and Michael Bates. Their work appears in journals such as Cancer Epidemiology Biomarkers & Prevention, International Journal of Cancer, Occupational and Environmental Medicine, PLoS ONE and JNCI Journal of the National Cancer Institute.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Lee E. Moore

Impact in

Papers in i

In The Last Decade

Lee E. Moore

Lee E. Moore's Hit Papers

Peers

Countries citing papers authored by Lee E. Moore

Fields of papers citing papers by Lee E. Moore

All Works

About Lee E. Moore

Explore authors with similar magnitude of impact

Papers in